ALLOGENEIC TRANSPLANTATION IN ACUTE MYELOID LEUKEMIA IN THE ERA OF NOVEL THERAPIES: CHANGING INDICATIONS AND DYNAMIC RISK ASSESSMENT. Mediterr J Hematol Infect Dis [Internet]. 2026 Oct. 31 [cited 2026 Nov. 1];18(1):e2026088. Available from: https://www.mjhid.org/mjhid/article/view/6552